Document is current
Any future updates will be listed below
-
Authors
Lane, Morgan D.
Kishnani, Sujata
Udemadu, Obianuju
Danquah, Samuel Eshun
Treadway, Robert M. III
Langman, Aaliyah
Balevic, Stephen
Jackson, Wesley M.
Laughon, Matthew https://orcid.org/0000-0002-4052-3215
Hornik, Christoph P.
Greenberg, Rachel G. https://orcid.org/0000-0003-4156-8543
Clark, Reese H. https://orcid.org/0000-0002-7363-4640
Zimmerman, Kanecia O. https://orcid.org/0000-0003-3748-6932
- License Information
-
More Information
Article History
Received: 12 November 2020
Revised: 25 May 2021
Accepted: 23 June 2021
First Online: 20 July 2021
Competing interests
: MDL: research support from Duke BIGGER Program. SB: support from the National Institutes of Health, FDA, PCORI, the Rheumatology Research Foundation’s Scientist Development Award, the Thrasher Research Fund, the Childhood Arthritis and Rheumatology Research Alliance, and consulting for UCB. KOZ: support from the National Institutes of Health (National Institute of Child Health and Human Development (K23 HD091398, HHSN275201000003I), the US FDA (UG3/UH3 FD 006797), the Duke Clinical and Translational Science Award (KL2TR001115-03), and industry for neonatal and pediatric drug development (). All other authors report no competing interests relevant to this paper.
: The Duke IRB approved this study with a waiver of consent.
